Literature DB >> 11496851

Dysfunction of endothelial protein C activation in severe meningococcal sepsis.

S N Faust1, M Levin, O B Harrison, R D Goldin, M S Lockhart, S Kondaveeti, Z Laszik, C T Esmon, R S Heyderman.   

Abstract

BACKGROUND: Impairment of the protein C anticoagulation pathway is critical to the thrombosis associated with sepsis and to the development of purpura fulminans in meningococcemia. We studied the expression of thrombomodulin and the endothelial protein C receptor in the dermal microvasculature of children with severe meningococcemia and purpuric or petechial lesions.
METHODS: We assessed the integrity of the endothelium and the expression of thrombomodulin and the endothelial protein C receptor in biopsy specimens of purpuric lesions from 21 children with meningococcal sepsis (median age, 41 months), as compared with control skin-biopsy specimens.
RESULTS: The expression of endothelial thrombomodulin and of the endothelial protein C receptor was lower in the patients with meningococcal sepsis than in the controls, both in vessels with thrombosis and in vessels without thrombosis. On electron microscopical examination, the endothelial cells were generally intact in both thrombosed and nonthrombosed vessels. Plasma thrombomodulin levels in the children with meningococcal sepsis (median, 6.4 ng per liter) were higher than those in the controls (median, 3.6 ng per liter; P=0.002). Plasma levels, protein C antigen, protein S antigen, and antithrombin antigen were lower than those in the controls. In two patients treated with unactivated protein C concentrate, activated protein C was undetectable at the time of admission, and plasma levels remained low.
CONCLUSIONS: In severe meningococcal sepsis, protein C activation is impaired, a finding consistent with down-regulation of the endothelial thrombomodulin-endothelial protein C receptor pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11496851     DOI: 10.1056/NEJM200108093450603

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  117 in total

1.  Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans.

Authors:  Esther B Bachli; Stephan R Vavricka; Roland B Walter; Monika I Leschinger; Marco Maggiorini
Journal:  Intensive Care Med       Date:  2003-01-15       Impact factor: 17.440

Review 2.  Disseminated intravascular coagulation: old disease, new hope.

Authors:  Cheng Hock Toh; Michael Dennis
Journal:  BMJ       Date:  2003-10-25

3.  Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo.

Authors:  O B Harrison; B D Robertson; S N Faust; M A Jepson; R D Goldin; M Levin; R S Heyderman
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

Review 4.  Pathophysiology of meningococcal meningitis and septicaemia.

Authors:  N Pathan; S N Faust; M Levin
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

Review 5.  Emerging therapies in severe sepsis.

Authors:  S J Finney; T W Evans
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 6.  The endothelium: physiological functions and role in microcirculatory failure during severe sepsis.

Authors:  H Ait-Oufella; E Maury; S Lehoux; B Guidet; G Offenstadt
Journal:  Intensive Care Med       Date:  2010-05-05       Impact factor: 17.440

Review 7.  New insights into modulation of thrombin formation.

Authors:  Henri M H Spronk; Julian I Borissoff; Hugo ten Cate
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

8.  Cell painting with an engineered EPCR to augment the protein C system.

Authors:  Eveline A M Bouwens; Fabian Stavenuiter; Laurent O Mosnier
Journal:  Thromb Haemost       Date:  2015-08-13       Impact factor: 5.249

9.  Protein C concentrate to restore physiological values in adult septic patients.

Authors:  Fabio Baratto; Flavio Michielan; Muzio Meroni; Antonella Dal Palù; Annalisa Boscolo; Carlo Ori
Journal:  Intensive Care Med       Date:  2008-05-06       Impact factor: 17.440

Review 10.  The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications.

Authors:  Silvio Danese; Stefania Vetrano; Li Zhang; Victoria A Poplis; Francis J Castellino
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.